Method for producing curative canine parvovirus virus monoclonal antibody by using bioreactor
A monoclonal antibody and canine parvovirus technology, applied in biochemical equipment and methods, microorganisms, anti-animal/human immunoglobulin, etc., can solve the problems of large batch-to-batch variation, inappropriateness, and low yield
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0008] In one embodiment, the present invention provides a method for producing a therapeutic canine parvovirus monoclonal antibody, comprising the steps of:
[0009] (1) Inoculate the hybridoma cells secreting anti-canine parvovirus monoclonal antibody into the culture medium in the bioreactor;
[0010] (2) cultivating hybridoma cells in a bioreactor;
[0011] (3) Harvest the anti-canine parvovirus monoclonal antibody produced by the hybridoma cells.
[0012] In the present invention, "bioreactor" refers to a bioreaction device that provides a good closed environment for culturing growing and non-immobilized cells, and is usually also called a cell fermenter. A variety of bioreactors may be suitable for use in the present invention, including, for example, stirred bioreactors, airlift bioreactors, hollow fiber bioreactors, and fluidized bed bioreactors, among others.
[0013] There are three main types of bioreactor cell culture: batch, fed-batch and perfusion. In simple b...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com